Oct 2 (Reuters) - Theriva Biologics Inc TOVX.A:
THERIVA BIOLOGICS INC - APPROVES PLAN TO RESTRUCTURE COMPANY - SEC FILING
THERIVA BIOLOGICS INC - IMPLEMENTS 32% WORKFORCE REDUCTION - SEC FILING
THERIVA BIOLOGICS INC: EXPECTS WILL EXTEND ITS CASH RUNWAY INTO Q2 OF 2026
Source text: [ID:n0001104659-25-096047]
Further company coverage: TOVX.A
((Reuters.Briefs@thomsonreuters.com;))